$BGNE BeiGene, Ltd. Insider Trading Week 35/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BeiGene, Ltd. in week 35/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.78 | 2,016 | 473,308 | 0 | 2 K to 0 (-100.00 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.28 | 3,018 | 707,062 | 2,016 | 5 K to 2 K (-59.95 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 232.70 | 1,455 | 338,578 | 5,034 | 6.5 K to 5 K (-22.42 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 231.52 | 1,905 | 441,046 | 6,489 | 8.4 K to 6.5 K (-22.69 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 230.50 | 3,300 | 760,641 | 8,394 | 11.7 K to 8.4 K (-28.22 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 228.92 | 610 | 139,643 | 11,694 | 12.3 K to 11.7 K (-4.96 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 228.08 | 1,802 | 410,995 | 12,304 | 14.1 K to 12.3 K (-12.77 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 226.97 | 8,019 | 1,820,064 | 14,106 | 22.1 K to 14.1 K (-36.24 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 226.07 | 4,482 | 1,013,258 | 22,125 | 26.6 K to 22.1 K (-16.85 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 224.52 | 1,200 | 269,428 | 26,607 | 27.8 K to 26.6 K (-4.32 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 239.63 | 900 | 215,665 | 0 | 900 to 0 (-100.00 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 238.46 | 1,000 | 238,461 | 900 | 1.9 K to 900 (-52.63 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.27 | 647 | 153,511 | 1,900 | 2.5 K to 1.9 K (-25.40 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 236.12 | 1,904 | 449,580 | 2,547 | 4.5 K to 2.5 K (-42.78 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.98 | 1,228 | 288,555 | 4,451 | 5.7 K to 4.5 K (-21.62 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 234.28 | 4,290 | 1,005,045 | 5,679 | 10 K to 5.7 K (-43.03 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 232.86 | 3,401 | 791,969 | 9,969 | 13.4 K to 10 K (-25.44 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 231.92 | 2,959 | 686,250 | 13,370 | 16.3 K to 13.4 K (-18.12 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 230.87 | 3,945 | 910,773 | 16,329 | 20.3 K to 16.3 K (-19.46 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 242.81 | 42 | 10,198 | 0 | 42 to 0 (-100.00 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 242.16 | 3,312 | 802,017 | 42 | 3.4 K to 42 (-98.75 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 241.14 | 5,707 | 1,376,172 | 3,354 | 9.1 K to 3.4 K (-62.98 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 240.15 | 2,200 | 528,326 | 9,061 | 11.3 K to 9.1 K (-19.54 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 239.09 | 600 | 143,452 | 11,261 | 11.9 K to 11.3 K (-5.06 %) |
| Sep 02 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.82 | 1,100 | 261,599 | 11,861 | 13 K to 11.9 K (-8.49 %) |
| Sep 01 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 39,000 | 88,530 | 402,575 | |
| Sep 01 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 244.93 | 300 | 73,478 | 0 | 300 to 0 (-100.00 %) |
| Sep 01 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 243.49 | 700 | 170,442 | 300 | 1,000 to 300 (-70.00 %) |
| Sep 01 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 242.41 | 1,000 | 242,413 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Sep 01 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 240.86 | 200 | 48,172 | 2,000 | 2.2 K to 2 K (-9.09 %) |
| Sep 01 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 240.15 | 800 | 192,121 | 2,200 | 3 K to 2.2 K (-26.67 %) |
| Sep 01 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 3,000 | 88,470 | 3,000 | 0 to 3 K |